2.20 USD
↗ 0.03 (1.15%)AT CLOSE (11:59 AM EDT)
XBiotech Inc
XBITNASDAQ • USD
2.19
↘ 0.01 (0.46%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.19
↘ 0.01 (0.46%)
Market: CLOSED
Shares of XBiotech Inc (XBIT) are trading at $2.20. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, XBIT appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 15, 2026.
Open?$2.17
High?$2.20
Low?$2.16
Prev. Close?$2.17
Volume?18.2K
Avg. Volume?43.2K
VWAP?$2.19
Rel. Volume?0.42x
Bid / Ask
Bid?$2.17 × 200
Ask?$2.42 × 600
Spread?$0.25
Midpoint?$2.30
Valuation & Ratios
Market Cap?67.1M
Shares Out?30.5M
Float?16.7M
Float %?54.8%
P/E Ratio?N/A
P/B Ratio?0.52
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Themes
Employees
87
Market Cap
66.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-04-15
Address
5217 WINNEBAGO LANE
AUSTIN, TX 78744
Phone: 512-386-2900
AUSTIN, TX 78744
Phone: 512-386-2900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?23
Short Sent.?65
Piotroski F-Score?0/9Weak
Altman Z-Score?5.87Safe
Confidence?43%Low
Short InterestVery High
Short % of Float?2.05%Low
Short Interest?342.8K
Days to Cover?13.2
Free Float16.7M
Avg Daily Volume26.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?33.15Strong
Quick Ratio?33.15Strong
Cash Ratio?32.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.52CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.9CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-35.1%WEAK▾
S&P5
ROA?-33.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-40839000
Enterprise Value?$-42454992
Fundamentals ratios updated end of day